Clinical Scorecard: Outcomes of Neoadjuvant Chemoradiotherapy and Surgery in Older Adults with Locally Advanced Rectal Cancer: Insights from a Multicenter Study

At a Glance

Key Highlights

• Standard treatment for LARC involves nCRT followed by surgery, improving oncologic outcomes but often limited in elderly due to comorbidities and frailty.
• Textbook Oncologic Outcome (TOO) is a composite quality metric integrating surgical and oncologic benchmarks to assess treatment completeness and quality.
• In this study of 157 elderly patients, 98% achieved R0 resection with low severe complication rates (8.9%) and no 90-day mortality, demonstrating feasibility of multimodal treatment.

Guideline-Based Recommendations

Diagnosis

• Use clinical staging with CT and MRI to define locally advanced disease (cT3-4 and/or cN+).
• Define tumor location as mid-to-lower rectum if ≤ 10 cm from anal verge on MRI.

Management

• Employ neoadjuvant chemoradiotherapy followed by low anterior resection (LAR) for curative intent in LARC.
• Prefer minimally invasive surgical approaches when feasible, with ostomy creation (mostly ileostomy) and planned reversal.
• Exclude patients with metastatic disease or requiring abdominoperineal resection or pelvic exenteration from this treatment protocol.

Monitoring & Follow-up

• Monitor postoperative complications using Clavien-Dindo classification; aim for absence of major complications (grade < 3b).
• Track length of hospital stay, readmission within 30 days, and 90-day mortality as quality indicators.
• Follow patients longitudinally for overall survival and recurrence using appropriate statistical methods.

Risks

• Higher prevalence of comorbidities and frailty in elderly may increase risk of undertreatment and poorer cancer-specific survival.
• Potential for postoperative morbidity necessitates careful patient selection and perioperative management.
• Reduced lymph node yield after nCRT should be considered when evaluating surgical pathology.

Patient & Prescribing Data

Elderly patients (≥ 70 years) with locally advanced mid-to-lower rectal adenocarcinoma undergoing nCRT and surgery

High rates of R0 resection (98%) and low severe complication rates (8.9%) indicate that multimodal treatment is feasible and safe in selected elderly patients; ileostomy reversal achieved in 77% with median 174 days to reversal.

Clinical Best Practices

• Adopt a multidisciplinary approach to balance oncologic efficacy and treatment-related morbidity in elderly patients.
• Use Textbook Oncologic Outcome (TOO) criteria to evaluate quality and completeness of treatment.
• Prefer minimally invasive surgery when possible to reduce morbidity.
• Ensure comprehensive preoperative staging and patient assessment to optimize treatment selection.
• Monitor postoperative outcomes closely to identify and manage complications early.

References

• Colorectal cancer incidence and mortality statistics
• AJCC 8th edition staging system for colorectal cancer
• Italian expert consensus on colorectal surgery TOO criteria